Aichi Medical University Hospital

Nagakute-shi, Aichi-ken 480-1195

1 studies enrolling now · 12 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis (ALS), Atopic Dermatitis, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Colorectal Cancer (CRC), Diabetic Macular Edema, Dyslipidemia, Hemi-retinal Vein Occlusion, Neovascular Age-related Macular Degeneration, Nonalcoholic Steatohepatitis, Retinal Vein Occlusion

Studies at this site

• A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease — Recruiting now
• Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) — Recruiting now
• A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) — Completed
• Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation — Completed
• Safety Study of Oral Edaravone Administered in Subjects With ALS — Completed
• Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS) — Completed
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed